You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,193,229


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,193,229
Title:Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
Abstract: Disclosed are methods of treating a hyperproliferative disorder or a disease related to vasculogenesis or angiogenesis in a mammal, comprising administering to said mammal an effective amount of a compound of the formula ##STR00001## or a pharmaceutically accepted salt thereof, wherein A, R.sup.1, R.sup.2, R.sup.7, R.sup.8, and R.sup.9 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals.
Inventor(s): Wallace; Eli M. (Boulder, CO), Lyssikatos; Joseph P. (Piedmont, CA), Marlow; Allison L. (Boulder, CO), Hurley; T. Brian (Boulder, CO)
Assignee: Array Biopharma Inc. (Boulder, CO)
Application Number:12/824,521
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,193,229: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 8,193,229, focusing on its claims, scope, and the broader patent landscape.

Overview of United States Patent 8,193,229

United States Patent 8,193,229, titled "Method of Treatment Using N3 Alkylated Benzimidazole Derivatives as MEK Inhibitors," was assigned to Array BioPharma Inc. and later involved in a patent term extension application[2].

Patent Title and Abstract

The patent pertains to methods of treating various diseases, including cancer, using N3 alkylated benzimidazole derivatives as MEK inhibitors. MEK (mitogen-activated protein kinase kinase) inhibitors are a class of drugs that target the MEK enzyme, which is involved in cell signaling pathways.

Assignees and Ownership

The patent was originally assigned to Array BioPharma Inc. and later involved in transactions that may have changed its ownership or licensing agreements[2].

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations.

  • Independent Claims: These claims outline the core invention, such as the specific compounds and their use in treating diseases.
  • Dependent Claims: These claims build upon the independent claims by adding specific details, like the dosage, administration method, or particular diseases treated.

Claim Scope

The scope of the claims determines the extent of protection granted by the patent. For U.S. Patent 8,193,229, the claims cover:

  • Specific chemical compounds (N3 alkylated benzimidazole derivatives)
  • Methods of using these compounds as MEK inhibitors
  • Treatment of various diseases, including cancer

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial for determining infringement and validity. The claims in this patent would be constructed based on the language used, the specification, and any relevant prosecution history[3].

Patent Landscape

Prior Art and Citation Data

To understand the patent landscape, it is essential to look at prior art and citation data. Tools like the Common Citation Document (CCD) and Patent Public Search can provide insights into the prior art cited by various patent offices for related applications[1].

  • Prior Art: The CCD application consolidates citation data from participating IP offices, helping to identify relevant prior art that may affect the validity or scope of the patent.
  • Citation Data: Analyzing citation data can reveal how the patent fits into the broader technological field and its impact on subsequent inventions.

Global Patent Family

Using services like Global Dossier, one can view the patent family for this specific application, including related applications filed at participating IP offices. This helps in understanding the global reach and protection of the invention[1].

Search and Analysis Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and analyzing patent applications. It offers modern interfaces and enhanced access to prior art, improving the overall patent searching process[1].

Global Dossier

Global Dossier provides access to file histories, classification, and citation data for related applications, helping users to identify office actions and manage collections of documents[1].

Other International Databases

Databases such as Espacenet (European Patent Office), Patentscope (WIPO), and national patent offices' databases (e.g., Japan, China) can be used to search for similar patents globally[1][4].

Economic and Strategic Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the scope and claims of patents, including statistical analysis of claim-level data. This dataset can help in understanding the trends and measurements of patent scope[3].

Market Impact

The patent's impact on the market can be significant, especially in the pharmaceutical industry where MEK inhibitors are a critical class of drugs. Understanding the patent landscape helps companies navigate licensing agreements, avoid infringement, and develop new innovations.

Legal and Regulatory Considerations

Patent Term Extension

The patent was involved in a patent term extension application, which can extend the life of the patent under certain conditions. This is often sought to compensate for delays in the regulatory approval process[2].

Office Actions and Prosecution History

Analyzing office actions and the prosecution history can provide valuable insights into the patent's validity and scope. This information is available through tools like the Patent Examination Data System (PEDS)[1].

Practical Applications and Future Directions

Research and Development

For researchers and developers, understanding the claims and scope of this patent is essential for developing new MEK inhibitors or improving existing ones without infringing on the protected invention.

Licensing and Collaboration

Companies may need to negotiate licensing agreements or collaborate with the patent holders to use the protected technology. A thorough analysis of the patent landscape is crucial for these negotiations.

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is vital for determining the scope of protection.
  • Patent Landscape: Analyzing prior art, citation data, and global patent families helps in understanding the broader technological field.
  • Search Tools: Utilizing tools like Patent Public Search, Global Dossier, and international databases is essential for comprehensive analysis.
  • Economic Implications: The patent's impact on the market, especially in the pharmaceutical industry, is significant.
  • Legal Considerations: Understanding patent term extensions, office actions, and prosecution history is crucial for legal and regulatory compliance.

FAQs

What is the main subject of United States Patent 8,193,229?

The main subject of this patent is the method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors.

How can I search for prior art related to this patent?

You can use tools like the USPTO's Patent Public Search, Global Dossier, and the Common Citation Document (CCD) to search for prior art.

What databases can I use to search for similar patents globally?

You can use databases such as Espacenet, Patentscope, and national patent offices' databases like those of Japan and China.

What is the significance of the Patent Claims Research Dataset?

The Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, helping in statistical analysis and understanding patent scope trends.

How can I determine if a product or process infringes on this patent?

To determine infringement, you need to conduct a thorough analysis of the claims, compare them with your product or process, and possibly consult with a patent attorney.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Regulations.gov - Patent Term Extension Application: https://www.regulations.gov/docket/FDA-2019-E-3051
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Harvard Business School Library - Patent search: A comparative table of databases: https://asklib.library.hbs.edu/faq/266950

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,193,229

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,193,229

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1482932 ⤷  Subscribe PA2019007 Lithuania ⤷  Subscribe
European Patent Office 1482932 ⤷  Subscribe LUC00100 Luxembourg ⤷  Subscribe
European Patent Office 1482932 ⤷  Subscribe 300974 Netherlands ⤷  Subscribe
European Patent Office 1482932 ⤷  Subscribe 2019C/510 Belgium ⤷  Subscribe
European Patent Office 1482932 ⤷  Subscribe CA 2019 00011 Denmark ⤷  Subscribe
European Patent Office 1482932 ⤷  Subscribe C20190010 00281 Estonia ⤷  Subscribe
European Patent Office 1482932 ⤷  Subscribe 14/2019 Austria ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.